Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 9. Nadolol: a new long-acting beta-adrenoceptor blocking drug

American Heart Journal
W Frishman

Abstract

No abstract listed.

References

Jan 1, 1976·European Journal of Pharmacology·D B EvansR J Laffan
May 1, 1977·Journal of Clinical Pharmacology·J DreyfussD A Willard
Sep 1, 1973·British Medical Journal·C J Bulpitt, C T Dollery

Citations

Nov 1, 1992·Journal of Clinical Pharmacology·A V MehtaP J Rice
Jan 1, 1985·European Journal of Clinical Pharmacology·G HasenfussH Just
Mar 1, 1992·Journal of the American College of Cardiology·A V Mehta, B Chidambaram
Nov 1, 1983·Journal of the American College of Cardiology·M S ChangB N Chiang
Sep 17, 1981·The New England Journal of Medicine·W H Frishman
Jan 1, 1985·The British Journal of Ophthalmology·J WilliamsonJ G Muir
Feb 1, 1982·British Heart Journal·P CoumelP Attuel
Jun 1, 1981·Disease-a-month : DM·J W Moses, J S Borer
Jan 1, 1986·Journal of Clinical Pharmacology·F S CarusoR A Vukovich
Apr 1, 1982·Journal of Clinical Pharmacology·D T O'ConnorK L Duchin
Jan 1, 1982·British Journal of Clinical Pharmacology·S G Carruthers
Aug 27, 1981·The New England Journal of Medicine·J Koch-Weser, W H Frishman

Related Concepts

Adrenergic beta-Antagonists
Angina Pectoris
Metazoa
Cardiac Arrhythmia
Felis catus
Cavia porcellus
Half-Life
Hemodynamics
Hypertensive Disease
Propanolamines

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.